Steven AR Murphy: When Nighttime Medicine Turns Against the Heart
Steven AR Murphy, Medical Director, Concierge Medical Associates, shared a post on LinkedIn:
”The Melatonin Paradox: When Nighttime Medicine Turns Against the Heart
A new AHA study of over 130,000 adults has challenged one of the most common “natural” sleep aids. Beware but don’t jump to conclusions just yet, the Press and the American Heart Association have created a firestorm by Embargoing this press release…..
Long-term melatonin users—those taking it nightly for a year or more—had a 90% higher risk of heart failure and nearly double the mortality rate compared with matched non-users.
A secondary analysis found:
Participants taking melatonin were nearly 3.5 times as likely to be hospitalized for heart failure when compared to those not taking melatonin (19.0% vs. 6.6%, respectively).
Melatonin isn’t a sedative—it’s a circadian signal.
Chronic, off-timed supplementation may flatten the body’s internal rhythm, desynchronize cardiac mitochondrial clocks, and blunt the nightly repair processes that protect the heart.
At the cellular level, excess melatonin can suppress adaptive oxidative signaling, alter AMPK–mTOR balance, and reduce mitochondrial resilience. Over time, that quiet disruption becomes measurable heart dysfunction.
The lesson:
Sleep medicine must evolve into circadian medicine.
We need to restore light, temperature, and metabolic rhythm—not override them with nightly hormones. At Concierge Medical Associates we have a program dedicated for that where we work with Sleep Specialist Sahil Chopra, MD and his team at Empower Sleep
Safe strategies:
- Morning sunlight, evening darkness
- Cooling the body before bed
- Nutrients like magnesium, NR, and urolithin A to keep mitochondrial timekeepers synchronized
Melatonin should whisper in the dark, not shout for years.
Full analysis on Longevity Insider.
To A Life Well Lived,
-Dr. M.”
Stay updated with Hemostasis Today.
-
May 15, 2026, 16:35David Murdock: Identifying High-Risk Variants of Uncertain Significance in Aortopathy Genes
-
May 15, 2026, 16:35Maeva May: How Do You Drive Global Change In Stroke? Check Out The WSO Report
-
May 15, 2026, 16:30Carl Robertson: 12 Evidence-Based Recommendations for Stroke Prevention in PFO
-
May 15, 2026, 16:27Lenae Goolsby: How We Target the Root Source of Joint Pain for Lasting Recovery
-
May 15, 2026, 16:22Shayan Mohammadmoradi: Supporting Cardiovascular Research Through Community Action
-
May 15, 2026, 16:10Sawrav Kr Sanyal: PE Prevention Through Lifestyle and Awareness
-
May 15, 2026, 15:54Seema Dawood: Morphologic Differences Between Platelet Types
-
May 15, 2026, 15:48Elyse Moritz: First Large-Scale Study on Combined Neonatal Alloimmune Neutropenia and Thrombocytopenia
-
May 15, 2026, 15:46Alexandre Becker: Clinical Importance of Neonatal Thrombocytopenia in Newborns